Alligator Bioscience AB (OSTO:ATORX) Cyclically Adjusted Book per Share: kr83.52 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:ATORX Alligator Bioscience AB OSTO:ATORX
39 GF Score
Price kr0.17
GF Value kr0.01
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Alligator Bioscience AB Cyclically Adjusted Book per Share?

Alligator Bioscience AB OSTO:ATORX -3.60% 39 Cyclically Adjusted Book per Share is kr83.52 as of Mar. 2026. GuruFocus rates OSTO:ATORX with a GF Score™ of 39/100 and a GF Value™ of kr0.01 (Significantly Overvalued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Alligator Bioscience AB's adjusted book value per share for the three months ended in Mar. 2026 was kr0.066. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr83.52 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Alligator Bioscience AB's average Cyclically Adjusted Book Growth Rate was -10.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-13), Alligator Bioscience AB's current stock price is kr0.1712. Alligator Bioscience AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was kr83.52. Alligator Bioscience AB's Cyclically Adjusted PB Ratio of today is 0.00.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of Alligator Bioscience AB was 0.03. The lowest was 0.01. And the median was 0.02.


Alligator Bioscience AB  (OSTO:ATORX) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Alligator Bioscience AB's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.1712/83.52
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PB Ratio of Alligator Bioscience AB was 0.03. The lowest was 0.01. And the median was 0.02.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Alligator Bioscience AB Cyclically Adjusted Book per Share Related Terms


Alligator Bioscience AB Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Alligator Bioscience AB's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alligator Bioscience AB Cyclically Adjusted Book per Share Chart

Alligator Bioscience AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 85.61

Alligator Bioscience AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 92.78 92.60 90.02 85.61 83.52

OSTO:ATORX vs VRTX, REGN, ALNY: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Alligator Bioscience AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alligator Bioscience AB Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alligator Bioscience AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Alligator Bioscience AB's Cyclically Adjusted PB Ratio falls into.


OSTO:ATORX
39GF Score
Alligator Bioscience AB OSTO:ATORX
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alligator Bioscience AB Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Alligator Bioscience AB's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.066/133.5600*133.5600
=0.066

Current CPI (Mar. 2026) = 133.5600.

Alligator Bioscience AB Quarterly Data

Book Value per Share CPI Adj_Book
201606 0.000 101.019 0.000
201609 115.964 101.138 153.140
201612 207.355 102.022 271.456
201703 203.023 102.022 265.785
201706 193.537 102.752 251.564
201709 185.648 103.279 240.080
201712 189.499 103.793 243.846
201803 176.607 103.962 226.887
201806 165.071 104.875 210.222
201809 152.953 105.679 193.307
201812 143.609 105.912 181.098
201903 130.035 105.886 164.020
201906 114.938 106.742 143.816
201909 97.580 107.214 121.559
201912 79.270 107.766 98.244
202003 66.136 106.563 82.891
202006 55.376 107.498 68.802
202009 45.920 107.635 56.980
202012 35.340 108.296 43.584
202103 41.899 108.360 51.643
202106 32.581 108.928 39.949
202109 22.656 110.338 27.424
202112 31.884 112.486 37.857
202203 26.941 114.825 31.337
202206 21.826 118.384 24.624
202209 16.069 122.296 17.549
202212 10.059 126.365 10.632
202303 2.996 127.042 3.150
202306 8.032 129.407 8.290
202309 5.117 130.224 5.248
202312 0.741 131.912 0.750
202403 -3.180 132.205 -3.213
202406 -0.516 132.716 -0.519
202409 -4.122 132.304 -4.161
202412 -7.067 132.987 -7.097
202503 -2.850 132.825 -2.866
202506 -0.485 133.699 -0.484
202509 -0.103 133.480 -0.103
202512 0.014 133.390 0.014
202603 0.066 133.560 0.066

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of kr83.52 mean?
Alligator Bioscience AB (OSTO:ATORX) has a Cyclically Adjusted Book per Share of kr83.52 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Alligator Bioscience AB and its competitors.
Is Alligator Bioscience AB's Cyclically Adjusted Book per Share too high?
Alligator Bioscience AB's current Cyclically Adjusted Book per Share is kr83.52. Overall, Alligator Bioscience AB has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Alligator Bioscience AB's Cyclically Adjusted Book per Share compare to VRTX and REGN?
Alligator Bioscience AB's Cyclically Adjusted Book per Share of kr83.52 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Alligator Bioscience AB and its competitors. Alligator Bioscience AB's current Cyclically Adjusted Book per Share is kr83.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alligator Bioscience AB stock overvalued right now?
Based on GuruFocus' analysis, Alligator Bioscience AB (OSTO:ATORX) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.01, compared to a current price of kr0.17 — trading 1612% above its estimated fair value. The current Cyclically Adjusted Book per Share is kr83.52. Alligator Bioscience AB's overall GF Score™ is 39/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Alligator Bioscience AB (OSTO:ATORX), the current Cyclically Adjusted Book per Share is kr83.52 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alligator Bioscience AB (OSTO:ATORX) Overvalued in 2026?

Based on GuruFocus' analysis, Alligator Bioscience AB stock appears to be overvalued. The current stock price of kr0.17 is trading 1612% above its estimated GF Value™ of kr0.01. GuruFocus considers Alligator Bioscience AB to be Significantly Overvalued.

Key valuation signals for OSTO:ATORX:

  • Cyclically Adjusted Book per Share: kr83.52
  • GF Value™: kr0.01 vs. price of kr0.17 (1612% above fair value)
  • GF Score™: 39/100 with 7 warning signs

No single metric tells the full story. See the OSTO:ATORX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Alligator Bioscience AB Business Description

Other Exchanges 0RK9:UK7AL0:Germany
Address Scheeletorget 1, Medicon Village, Lund, SWE, 223 81
Alligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs focused on the CD40 receptor. The company's main drug candidate, mitazalimab, is currently under development as a therapy for metastatic pancreatic cancer patients. Its development pipeline also comprises: ATOR-4066, a bispecific antibody targeting CD40, as well as CEACAM5 (carcinoembryonic antigen 5), a protein found in certain tumors; and certain externally developed programs like HLX22 and ALG.APV-527. Geographically, the company generates maximum revenue from Belgium (mainly through out-licensing), and also has its presence in Sweden and Finland.
39GF Score

Get the complete analysis for OSTO:ATORX

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.17
Price
kr0.01
GF Value